1092
T. Konno et al.
PAPER
N-Benzyl-N-(4,4,5,5,6,6-hexafluoro-1-phenylhex-2-ynyl)hy-
IR (neat): 3231, 2959, 2932, 2873, 2371, 2244, 1720, 1459, 1375,
1262, 1157, 1138, 1037, 861, 801, 737, 699, 499, 460 cm–1.
droxylamine (5k)
Dark brown solid; mp 100–103 °C.
1H NMR (400 MHz, CDCl3): d = 0.92 (t, J = 7.2 Hz, 3 H), 1.43–
1.53 (m, 2 H), 1.71–1.87 (m, 2 H), 3.65 (br s, 1 H), 3.84 (d, J = 13.2
Hz, 1 H), 4.08 (d, J = 12.4 Hz, 1 H), 4.72–4.78 (m, 1 H), 6.30 (t,
J = 55.2 Hz, 1 H), 7.27–7.38 (m, 5 H).
13C NMR (100 MHz, CDCl3): d = 13.6, 19.4, 34.5 (t, J = 1.6 Hz),
58.1–58.3 (m), 61.2–61.4 (m), 77.9 (t, J = 33.9 Hz), 86.7 (t, J = 7.4
Hz), 127.7, 128.5, 129.7, 136.5.
IR (KBr): 3240, 2927, 2371, 2258, 1720, 1497, 1455, 1262, 1224,
1089, 1026, 818, 697, 539, 494 cm–1.
1H NMR (400 MHz, CDCl3): d = 3.92 (d, J = 13.2 Hz, 1 H), 4.03 (d,
J = 13.2 Hz, 1 H), 4.89 (s, 1 H), 4.91 (s, 1 H), 6.16 (tt, J = 5.2, 52.0
Hz, 1 H), 7.27–7.52 (m, 10 H).
13C NMR (100 MHz, CDCl3): d = 60.5–60.9 (m), 62.1, 74.8 (t,
J = 36.3 Hz), 89.6 (t, J = 6.6 Hz), 104.7–110.7 (m, 3 C), 127.8,
128.5, 128.69, 128.74, 129.4, 130.9, 135.0, 136.4.
19F NMR (376 MHz, CDCl3): d = –105.3 (dd, J = 1.3, 12.1 Hz).
HRMS–FAB: m/z [M + H]+ calcd for C14H18F2NO: 254.1356;
found: 254.1351.
19F NMR (376 MHz, CDCl3): d = –137.1 (d quin, J = 7.5, 53.4 Hz,
2 F), –131.1 (m, 2 F), –99.9 (m, 2 F).
N-Benzyl-N-(4,4,5,5,6,6-hexafluoro-1-propylhex-2-ynyl)hy-
droxylamine (5i)
Brown solid; mp 43–45 °C.
HRMS–FAB: m/z [M + H]+ calcd for C19H16F6NO: 388.1136;
found: 388.1154.
IR (KBr): 3272, 3033, 2965, 2936, 2876, 2253, 1497, 1456, 1402,
1358, 1274, 1223, 1162, 1135, 998, 806, 745, 699 cm–1.
2-Benzyl-5-(1,1,2,2,3,3-hexafluoropropyl)-3-phenyl-2,3-dihy-
droisoxazole (6k)
Brown oil.
1H NMR (400 MHz, CDCl3): d = 0.94 (t, J = 7.6 Hz, 3 H), 1.45–
1.54 (m, 2 H), 1.73–1.89 (m, 2 H), 3.67 (m, 1 H), 3.83 (d, J = 13.2
Hz, 1 H), 4.07 (d, J = 13.2 Hz, 1 H), 4.78 (d, J = 6.0 Hz, 1 H), 6.14
(tt, J = 5.2, 52.0 Hz, 1 H), 7.28–7.35 (m, 5 H).
13C NMR (100 MHz, CDCl3): d = 13.5, 19.3, 34.2, 58.2, 61.2–61.7
(m), 73.2 (t, J = 36.3 Hz), 91.6 (t, J = 6.6 Hz), 105.1–110.8 (m, 3
H), 127.9, 128.5, 129.7, 136.3.
IR (neat): 3065, 3033, 2927, 2856, 1725, 1676, 1676, 1496, 1455,
1403, 1277, 1219, 1150, 1029, 980, 863, 802, 735, 698 cm–1.
1H NMR (400 MHz, CDCl3): d = 4.09 (d, J = 12.8 Hz, 1 H), 4.40 (d,
J = 13.2 Hz, 1 H), 5.07 (m, 1 H), 5.63–5.64 (m, 1 H), 6.02 (tt,
J = 5.2, 52.0 Hz, 1 H), 7.17–7.38 (m, 10 H).
13C NMR (100 MHz, CDCl3): d = 63.3, 72.8, 105.8 (t, J = 16.4 Hz),
107.4–110.8 (m, 3 C), 127.0, 128.0, 128.2, 128.5, 128.8, 129.5,
135.0, 139.6, 143.5.
19F NMR (376 MHz, CDCl3): d = –137.2 (d quin, J = 7.1, 51.5 Hz,
2 F), –131.5 (t, J = 4.9 Hz, 2 F), –99.7 (sext, J = 4.9 Hz, 2 F).
HRMS–FAB: m/z [M + H]+ calcd for C16H18F6NO: 354.1293;
found: 354.1301.
19F NMR (376 MHz, CDCl3): d = –137.5 to –137.2 (m, 2 F), –131.4
to –130.8 (m, 2 F), –116.2 to –112.4 (m, 2 F).
HRMS–FAB: m/z [M + H]+ calcd for C19H16F6NO: 388.1136;
found: 388.1143.
N-Benzyl-N-(4,4,4-trifluoro-1-phenylbut-2-ynyl)hydroxyl-
amine (5d)
Dark brown solid; mp 88–91 °C.
N-Benzyl-N-[1-(4-chlorophenyl)-4,4,4-trifluorobut-2-ynyl]hy-
droxylamine (5e)
Compounds 5e and 6e could not be purified by column chromatog-
raphy (silica gel). A small amount of a mixture of 5e and 6e was ob-
tained, and this was used to identify the two compounds.
1H NMR (400 MHz, CDCl3): d = 4.08 (d, J = 13.2 Hz, 1 H), 4.42 (d,
J = 12.4 Hz, 1 H), 4.87–4.91 (m, 1 H), 5.53 (q, J = 1.2 Hz, 1 H),
7.10–7.15 (m, 2 H), 7.26–7.36 (m, 7 H).
19F NMR (376 MHz, CDCl3): d = –64.87 (s, 3 F).
IR (KBr): 3423, 2926, 2370, 2251, 1638, 1498, 1457, 1268, 1135,
819, 755, 699, 555, 499 cm–1.
1H NMR (400 MHz, CDCl3): d = 3.93 (d, J = 12.8 Hz, 1 H), 4.05 (d,
J = 12.8 Hz, 1 H), 4.76 (s, 1 H), 4.90–4.93 (m, 1 H), 7.27–7.53 (m,
10 H).
13C NMR (100 MHz, CDCl3): d = 60.3–60.7 (m), 61.8–61.9 (m),
75.3 (q, J = 52.1 Hz), 83.8 (q, J = 6.6 Hz), 114.1 (q, J = 257.0 Hz),
127.9, 128.55, 128.69, 128.70, 128.78, 129.5, 134.9, 136.3.
19F NMR (376 MHz, CDCl3): d = –50.2 (s, 3 F).
HRMS–FAB: m/z [M + H]+ calcd for C17H14F3NO: 305.1027;
2-Benzyl-3-(4-chlorophenyl)-5-(trifluoromethyl)-2,3-dihydro-
isoxazole (6e)
1H NMR (400 MHz, CDCl3): d = 4.07 (d, J = 13.2 Hz, 1 H), 4.41 (d,
J = 12.4 Hz, 1 H), 5.02 (m, 1 H), 5.53 (q, J = 1.2 Hz, 1 H), 7.10–
7.15 (m, 2 H), 7.26–7.36 (m, 7 H).
found: 305.1030.
N-Benzyl-N-(4,4-difluoro-1-phenylbut-2-ynyl)hydroxylamine
(5j)
Yellow solid; mp 101–104 °C.
19F NMR (376 MHz, CDCl3): d = –67.63 (s, 3 F).
IR (KBr): 3231, 2918, 2370, 2251, 1726, 1453, 1373, 1265, 1147,
1044, 758, 739, 701, 523, 473 cm–1.
N-Benzyl-N-[4,4,4-trifluoro-1-(4-methoxyphenyl)but-2-
ynyl]hydroxylamine (5f)
1H NMR (400 MHz, CDCl3): d = 3.93 (d, J = 13.2 Hz, 1 H), 4.05 (d,
J = 13.2 Hz, 1 H), 4.78 (s, 1 H), 4.91 (br s, 1 H), 6.39 (t, J = 54.8
Hz, 1 H), 7.28–7.56 (m, 10 H).
Yellow oil.
IR (neat): 2500, 2962, 2370, 2245, 1736, 1610, 1516, 1459, 1264,
1139, 1035, 797, 701, 460 cm–1.
13C NMR (100 MHz, CDCl3): d = 60.1–60.5 (m), 61.9–62.0 (m),
79.5 (t, J = 33.8 Hz), 84.9 (t, J = 6.6 Hz), 103.6 (t, J = 232.2 Hz),
127.0, 127.8, 128.5, 128.6, 128.8, 129.6, 135.5–135.6 (m), 136.5.
19F NMR (376 MHz, CDCl3): d = –105.7 (dd, J = 4.9, 52.6 Hz).
HRMS–FAB: m/z [M + H]+ calcd for C17H16F2NO: 288.1200;
found: 288.1192.
1H NMR (400 MHz, CDCl3): d = 3.82 (s, 3 H), 3.88 (d, J = 12.4 Hz,
1 H), 3.98 (d, J = 12.4 Hz, 1 H), 4.83 (s, 1 H), 4.90 (s, 1 H), 6.91 (s,
1 H), 6.93 (s, 1 H), 7.28–7.43 (m, 7 H).
13C NMR (100 MHz, CDCl3): d = 55.3, 59.8–60.4 (m), 61.3–61.4
(m), 75.0 (q, J = 52.0 Hz), 84.2 (q, J = 6.6 Hz), 114.0, 114.1 (q,
J = 257.0 Hz), 126.8–126.9 (m), 127.8, 128.5, 129.6, 130.0, 136.4,
159.9.
Synthesis 2009, No. 7, 1087–1094 © Thieme Stuttgart · New York